- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Artery spasm.
Displaying page 1 of 1.
EudraCT Number: 2007-000510-37 | Sponsor Protocol Number: GTN-1 290107 | Start Date*: 2008-04-25 |
Sponsor Name:Nottingham Univeristy Hospitals NHS Trust | ||
Full Title: The effect of transdermal GTN on arterial size and procedure outcomes in transradial coronary angiography - pilot study. | ||
Medical condition: The trial is to investigate whether applying a transdermal GTN patch over the radial artery reduces spasm of the artery during coronary angiography. This is a pilot study | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2013-002457-30 | Sponsor Protocol Number: 13.0099 | Start Date*: 2013-09-13 | |||||||||||||||||||||
Sponsor Name:St George's University of London | |||||||||||||||||||||||
Full Title: An open label randomised controlled trial investigating the effect of donepezil on regional cerebral blood flow in adults with aneurysmal subarachnoid haemorrhage. | |||||||||||||||||||||||
Medical condition: Aneurysmal subarachnoid haemorrhage Cerebral vasospasm Ischaemic stroke | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-000321-12 | Sponsor Protocol Number: 001/2016 | Start Date*: 2018-02-08 | |||||||||||
Sponsor Name:ÁREA DE ATENCIÓN INTEGRADA DE ALBACETE | |||||||||||||
Full Title: Effectiveness in preventing RAdial Spasm of different vasoDIlators and topic Local Anaesthesia during transradial cardiac catheterization: The E-RADIAL trial. | |||||||||||||
Medical condition: Radial spasm during cardiac catheterization | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002721-18 | Sponsor Protocol Number: AC-054-203 | Start Date*: 2016-02-17 | ||||||||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd | ||||||||||||||||||
Full Title: A prospective, multi-center, open-label, single-arm, Phase 2 study to assess the efficacy and safety of clazosentan in reversing angiographically-confirmed cerebral vasospasm in adult subjects with... | ||||||||||||||||||
Medical condition: Aneurysmal subarachnoid hemorrhage (aSAH); cerebral vasospasm | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-002623-42 | Sponsor Protocol Number: 66623 | Start Date*: 2019-02-18 | |||||||||||
Sponsor Name:Academic Medical Center | |||||||||||||
Full Title: Vasospastic angina treatment by Endothelin Receptor Antagonism; a proof of concept study | |||||||||||||
Medical condition: Vasospastic angina, i.e. epicardial vasospasm or microvascular coronary dysfunction. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003518-41 | Sponsor Protocol Number: 2018-4765 | Start Date*: 2019-10-03 |
Sponsor Name:Radboudumc | ||
Full Title: Efficacy of Diltiazem to improve coronary microvascular dysfunction: A randomized clinical trial | ||
Medical condition: Coronary Microvascular Dysfunction (CMD). In CMD, ischemia is caused by impaired endothelial and/or non-endothelial coronary vasoreactivity resulting in the coronary microvasculature not dilating p... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-002453-31 | Sponsor Protocol Number: AC-054-201 | Start Date*: 2005-02-15 |
Sponsor Name:Actelion Pharmaceuticals Ltd. | ||
Full Title: A Phase IIb, multi-center, international, double-blind, randomized, placebo-controlled, parallel-group, dose-finding study for the prevention of cerebral vasospasm after aneurysmal subarachnoid hem... | ||
Medical condition: Prevention of ischaemic complications related to vasospasm in patients with aneurysmal subarachnoid haemorrhage | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) SE (Completed) FI (Completed) DE (Completed) IT (Completed) BE (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
